Pliant Therapeutics (PLRX) Leases (2021 - 2025)
Pliant Therapeutics (PLRX) has disclosed Leases for 5 consecutive years, with $24.0 million as the latest value for Q4 2025.
- On a quarterly basis, Leases fell 12.03% to $24.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $24.0 million, a 12.03% decrease, with the full-year FY2025 number at $24.0 million, down 12.03% from a year prior.
- Leases was $24.0 million for Q4 2025 at Pliant Therapeutics, down from $24.8 million in the prior quarter.
- In the past five years, Leases ranged from a high of $28.1 million in Q3 2024 to a low of $1.2 million in Q4 2023.
- A 5-year average of $13.4 million and a median of $6.1 million in 2024 define the central range for Leases.
- Peak YoY movement for Leases: tumbled 77.67% in 2023, then skyrocketed 2149.63% in 2024.
- Pliant Therapeutics' Leases stood at $6.3 million in 2021, then decreased by 14.34% to $5.4 million in 2022, then crashed by 77.67% to $1.2 million in 2023, then surged by 2149.63% to $27.2 million in 2024, then decreased by 12.03% to $24.0 million in 2025.
- Per Business Quant, the three most recent readings for PLRX's Leases are $24.0 million (Q4 2025), $24.8 million (Q3 2025), and $25.6 million (Q2 2025).